GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $938,000 | +95.8% | 13,771 | -8.1% | 0.02% | +36.4% |
| Q2 2022 | $479,000 | +75.5% | 14,982 | +90.6% | 0.01% | +266.7% |
| Q1 2022 | $273,000 | +28.2% | 7,859 | +7.7% | 0.00% | -25.0% |
| Q4 2021 | $213,000 | -3.6% | 7,297 | -15.7% | 0.00% | -33.3% |
| Q3 2021 | $221,000 | +145.6% | 8,661 | +237.1% | 0.01% | +200.0% |
| Q2 2021 | $90,000 | +200.0% | 2,569 | +253.4% | 0.00% | +100.0% |
| Q1 2021 | $30,000 | -94.6% | 727 | -94.3% | 0.00% | -94.1% |
| Q4 2020 | $555,000 | +354.9% | 12,819 | +479.3% | 0.02% | +1600.0% |
| Q3 2020 | $122,000 | -87.3% | 2,213 | -85.5% | 0.00% | -97.5% |
| Q2 2020 | $964,000 | +147.8% | 15,277 | +212.5% | 0.04% | +25.0% |
| Q4 2019 | $389,000 | +267.0% | 4,888 | +124.7% | 0.03% | +357.1% |
| Q3 2019 | $106,000 | -41.4% | 2,175 | -36.8% | 0.01% | -41.7% |
| Q2 2019 | $181,000 | +3520.0% | 3,440 | +3272.5% | 0.01% | – |
| Q1 2019 | $5,000 | -85.7% | 102 | -88.1% | 0.00% | -100.0% |
| Q4 2018 | $35,000 | -43.5% | 860 | -47.0% | 0.00% | -40.0% |
| Q3 2018 | $62,000 | +14.8% | 1,623 | +36.8% | 0.01% | +66.7% |
| Q2 2018 | $54,000 | -23.9% | 1,186 | -19.2% | 0.00% | -50.0% |
| Q1 2018 | $71,000 | +77.5% | 1,467 | +43.5% | 0.01% | +20.0% |
| Q4 2017 | $40,000 | +1900.0% | 1,022 | +1425.4% | 0.01% | – |
| Q3 2017 | $2,000 | -91.3% | 67 | -92.0% | 0.00% | -100.0% |
| Q2 2017 | $23,000 | +666.7% | 841 | +320.5% | 0.00% | – |
| Q4 2016 | $3,000 | -86.4% | 200 | -85.0% | 0.00% | -100.0% |
| Q2 2016 | $22,000 | +22.2% | 1,331 | +16.5% | 0.00% | -33.3% |
| Q1 2016 | $18,000 | +800.0% | 1,142 | +1656.9% | 0.00% | – |
| Q4 2015 | $2,000 | -98.0% | 65 | -97.2% | 0.00% | -100.0% |
| Q3 2015 | $99,000 | – | 2,330 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |